Industries > Pharma > Global Erythropoietin Market Forecast 2017-2027

Global Erythropoietin Market Forecast 2017-2027

Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing

PUBLISHED: 28 April 2017
PAGES: 164
PRODUCT CODE: PHA0187
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0187 Categories: , Tags: ,

The global erythropoietin market is expected to grow at a CAGR of 7.8% in the first half of the forecast period and CAGR of 4.8% in the second half of the forecast period. The market is estimated at $7.9bn in 2016 and $16.5bn in 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 84 tables and 93 figures – all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global erythropoietin market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Erythropoietin Market forecasts from 2017-2027

• Revenue forecasts of global erythropoietin market, segmented by product type:
– Epoetin Alfa
– Epoetin Beta
– Darbepoetin Alfa
– Biosimilars
– Others

This section also discusses the leading drugs as well as SWOT analysis of each submarket.

• Revenue forecasts of global erythropoietin market, segmented by application:
– Anemia (Cancer and HIV Treatment)
– Kidney Disorders (ESRD and Dialysis)
– Others

• Revenue forecasts of global erythropoietin API manufacturing market, segmented by contract manufacturing and in-house manufacturing

• Erythropoietin Leading Regional Market forecasts from 2017-2027 covering North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Global Erythropoietin Market Forecast 2017-2027

Forecast for each regional market is further segmented by product type, application and country:
– US
– Canada
– UK
– Germany
– France
– Spain
– Italy
– Rest of Europe
– China
– Japan
– India
– Rest of Asia-Pacific
– Brazil
– Mexico
– Rest of Latin America
– Saudi Arabia
– South Africa
– Rest of Middle East and Africa

• Assessment of selected leading companies that hold major market shares in the erythropoietin market:
– Amgen
– Johnson & Johnson
– Roche
– Biocon
– 3SBio
– Pfizer
– Kyowa Hakko Kirin Co Ltd
– LG Life Sciences Limited
– Intas Pharmaceuticals Ltd
– Novartis AG

Visiongain’s study is intended for anyone requiring commercial analyses for the erythropoietin market. You find data, trends and predictions.

Buy our report today Global Erythropoietin Market Forecast 2017-2027: Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Biosimilars, EPO API Manufacturing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Erythropoietin Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Erythropoietin Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category